Latest Hospitality News

HealthCo Healthcare & Wellness REIT reports FY25 results marked by suspended distributions amid Healthscope receivership, while maintaining strong portfolio fundamentals and active tenant resolution efforts.

HealthCo Healthcare & Wellness REIT posted solid FY25 financials amid ongoing tenant transition challenges with Healthscope. The REIT is proactively securing alternative tenants while maintaining a robust balance sheet.

HealthCo Healthcare and Wellness REIT reported a substantial $89.3 million loss for FY25, driven by tenant payment issues and portfolio downsizing, leading to suspended distributions and a debt facility extension.

Pro Medicus has delivered a landmark FY25 with soaring revenue and profit, driven by major contract wins and strategic cloud deployments. The company’s expanding North American footprint and AI initiatives set the stage for sustained growth.

Pro Medicus Limited has delivered a record-breaking FY2025 with soaring profits and a wave of major US healthcare contracts, setting the stage for continued expansion.

EBR Systems has secured FDA approval for its pioneering leadless WiSE CRT System and obtained key Medicare reimbursement endorsements, setting the stage for its commercial rollout. The company also completed a significant capital raise to support its market expansion.

Oneview Healthcare PLC reported a 36% increase in revenue for the first half of 2025, driven by strong deployment activity and new US customers, while managing a wider net loss due to FX impacts and restructuring costs.

Reef Casino Trust has received a revised $184.3 million takeover offer from Morris Group, intensifying a competitive bidding process with Iris Cairns Property. Unitholders are advised to hold off on decisions as the Independent Board Committee evaluates the proposals.

Donaco International Limited’s shares have been suspended from trading on the ASX following court approval of its acquisition by On Nut Road Limited. This marks a significant step in the company’s transition under new ownership.

AVITA Medical’s Q2 2025 update reveals a temporary setback in RECELL demand due to Medicare reimbursement delays, offset by strong revenue growth and promising clinical data. The company anticipates recovery and renewed growth in the second half of the year.

AVITA Medical reported a 21% increase in Q2 commercial revenue to $18.4 million and narrowed its net loss, yet faces a reimbursement hurdle that forced a downward revision of full-year guidance. The company highlights clinical progress and strategic board appointments as it navigates payment challenges.

Nanosonics has secured FDA clearance for its next-generation trophon3 device and trophon2 Plus software upgrade, setting the stage for significant growth in the US medical disinfection market.